AU4394201A - Insulin potentiating peptides - Google Patents

Insulin potentiating peptides

Info

Publication number
AU4394201A
AU4394201A AU4394201A AU4394201A AU4394201A AU 4394201 A AU4394201 A AU 4394201A AU 4394201 A AU4394201 A AU 4394201A AU 4394201 A AU4394201 A AU 4394201A AU 4394201 A AU4394201 A AU 4394201A
Authority
AU
Australia
Prior art keywords
insulin potentiating
potentiating peptides
peptides
insulin
potentiating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU4394201A
Inventor
Frank Man-Woon Ng
Woei-Ji Jiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metabolic Pharmaceuticals Pty Ltd
Original Assignee
Metabolic Pharmaceuticals Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPQ6618A external-priority patent/AUPQ661800A0/en
Application filed by Metabolic Pharmaceuticals Pty Ltd filed Critical Metabolic Pharmaceuticals Pty Ltd
Priority to AU2001243942A priority Critical patent/AU2001243942B2/en
Priority to AU4394201A priority patent/AU4394201A/en
Publication of AU4394201A publication Critical patent/AU4394201A/en
Pending legal-status Critical Current

Links

AU4394201A 2000-03-31 2001-03-30 Insulin potentiating peptides Pending AU4394201A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2001243942A AU2001243942B2 (en) 2000-03-31 2001-03-30 Insulin potentiating peptides
AU4394201A AU4394201A (en) 2000-03-31 2001-03-30 Insulin potentiating peptides

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPQ6618A AUPQ661800A0 (en) 2000-03-31 2000-03-31 Insulin-potentiating compounds
AU4394201A AU4394201A (en) 2000-03-31 2001-03-30 Insulin potentiating peptides
PCT/AU2001/000354 WO2001072770A1 (en) 2000-03-31 2001-03-30 Insulin potentiating peptides

Publications (1)

Publication Number Publication Date
AU4394201A true AU4394201A (en) 2001-10-08

Family

ID=25626565

Family Applications (2)

Application Number Title Priority Date Filing Date
AU4394201A Pending AU4394201A (en) 2000-03-31 2001-03-30 Insulin potentiating peptides
AU2001243942A Ceased AU2001243942B2 (en) 2000-03-31 2001-03-30 Insulin potentiating peptides

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001243942A Ceased AU2001243942B2 (en) 2000-03-31 2001-03-30 Insulin potentiating peptides

Country Status (1)

Country Link
AU (2) AU4394201A (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001199A (en) * 1974-03-26 1977-01-04 Takeda Chemical Industries, Ltd. Novel polypeptides useful for treating diabetes and hypercholesteremia
DE3855751T2 (en) * 1987-11-02 1997-04-24 Univ Monash HYPOGLYCEMIC PEPTIDES

Also Published As

Publication number Publication date
AU2001243942B2 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
GB0014870D0 (en) Peptides
NZ522924A (en) Neuroprotective peptides
EP1310252A4 (en) Injections
EP1268518A4 (en) Insulin potentiating peptides
GB9912852D0 (en) Peptides
EP1264611A4 (en) Syringe
GB0012291D0 (en) Pharmaceutical combination
GB0029777D0 (en) Peptides
EP1185558A4 (en) Peptide having preptin functionality
EP1147130A4 (en) Alpha-conotoxin peptides
EP1159288A4 (en) Alpha-conotoxin peptides
GB9904695D0 (en) Peptide
GB0001825D0 (en) Peptides
HK1053062A1 (en) Pernasally absorbable insulin preparations
GB9903408D0 (en) Peptides
GB9908920D0 (en) Peptide
AU4394201A (en) Insulin potentiating peptides
GB0021487D0 (en) Pharmaceutical
GB0007263D0 (en) Peptides
EP1151100A4 (en) Tau-conotoxin peptides
GB0012293D0 (en) Pharmaceutical combination
EP1323731A4 (en) Novel peptides
GB0010327D0 (en) Peptides
GB0007264D0 (en) Peptides
GB0021475D0 (en) Anti-aniogenic peptides